OncoCyte Corporation (OCX)
2.15
0.00 (0.00%)
At close: Jan 15, 2025, 12:36 PM
Price Reaction to Earnings Reports
This table provides an overview of how a stock's price historically reacted around earnings reports. It displays key metrics like price changes over specific timeframes and Relative Strength Index (RSI).
| Report Date | -3 Days | -2 Days | -1 Day | Open | High | Low | Close | +1 Day | +2 Days | +3 Days | +1 Week | -1 Week | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov 12, 2024
(Q3) AMC Q3 2024 | 2.86 | 2.90 | 3.00 | 3.00 | 3.00 | 2.81 | 2.94 | 2.80 | 2.61 | 2.63 | 2.75 | 2.84 | ||
IV: - RSI: 50 OCX % | 0.7% | 1.40% | 1.40% | 0.00%
| 0.00%
| -6.33%
| -2.00%
| -4.76% | -6.79% | 0.77% | 7.84% | -2.74% | ||
Aug 8, 2024
(Q2) AMC Q2 2024 | 3.05 | 3.00 | 3.08 | 2.96 | 3.34 | 2.96 | 3.12 | 2.96 | 3.05 | 3.02 | 3.05 | 2.95 | ||
IV: - RSI: 49 OCX % | 6.27% | -1.64% | -1.64% | -3.90%
| 8.44%
| -3.90%
| 1.30%
| -5.13% | 3.04% | -0.98% | 3.39% | -5.14% | ||
May 15, 2024
(Q1) AMC Q1 2024 | 2.89 | 2.90 | 2.95 | 2.70 | 3.09 | 2.70 | 3.07 | 2.93 | 2.76 | 2.82 | 2.83 | 2.87 | ||
IV: - RSI: 62 OCX % | 0% | 0.35% | 0.35% | -8.47%
| 4.75%
| -8.47%
| 4.07%
| -4.56% | -5.80% | 2.17% | -2.75% | 2.14% | ||
| Daily change and RSI 14 are based on the report date for BMO releases and the following day for AMC releases. | ||||||||||||||
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options Data
- Instant access to live options data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.